| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6043064 | World Neurosurgery | 2016 | 23 Pages |
Abstract
aPXA is associated with poorer clinical outcomes compared with PXA. Gross total resection should be the goal of initial treatment. It remains unclear whether adjuvant radiation and chemotherapy are able to prevent progression or dissemination. Long-term monitoring of all patients is a critical step in management due to the potential for tumors to transform into higher-grade lesions.
Keywords
PXASTRAnaplasticGTRUCSFGBMhpfPFsastrocytomaEORSubtotal resectionprogression-free survivaloverall survivalUniversity of California, San FranciscoTreatmentGross total resectionPleomorphic xanthoastrocytomaWorld Health OrganizationSurgeryOutcomesExtent of resectionhigh power fieldPleomorphicWHOGlioblastoma multiformeGlioblastomaGlioma
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Martin J. Rutkowski, Taemin Oh, Gulen G. Niflioglu, Michael Safaee, Tarik Tihan, Andrew T. Parsa,